Mapping of proteoglycans in atherosclerotic lesions

• Published in: European heart journal Vol. 11 Suppl E; p. 29
• Main Authors: Völker, W, Schmidt, A, Oortmann, W, Broszey, T, Faber, V, Buddecke, E
• Format: Journal Article
• Language: English
• Published: England 01.08.1990
• Subjects: Animals; Arteries - chemistry; Arteries - pathology; Arteriosclerosis - metabolism; Arteriosclerosis - pathology; Cholesterol - analysis; Glycosaminoglycans - analysis; Humans; Proteoglycans - ultrastructure
• ISSN: 0195-668X
• DOI: 10.1093/eurheartj/11.suppl_E.29

The involvement of sulphated glycosaminoglycans in atherosclerotic changes have been studied in human and rat arteries, and biochemical experiments have revealed that a significant increase in the contents of chondroitin sulphate/dermatan sulphate and cholesterol, but loss of heparan sulphate, occurs in human atherosclerotic arterial tissues. Electron micrographs have revealed that extracellular deposits of lipid are predominantly present in areas rich in chondroitin sulphate proteoglycans but not in areas rich in collagen bundles and dermatan sulphate proteoglycans. The different types of proteoglycans have been distinguished in situ by the cuprolinic blue staining method and enzymatic degradation experiments, and their topohistochemical distribution patterns analysed by morphometry of proteoglycan/cuprolinic blue precipitates. The ultracytochemical investigations indicate changes in size and pattern of chondroitin sulphate-rich proteoglycan-cuprolinic blue precipitates in human atherosclerosis. In plaque tissue, these precipitates are significantly enlarged. In addition, they accumulate around smooth muscle cells in the medial tissue. An increase in the size of proteoglycan-cuprolinic blue precipitates has also been observed in balloon catheter-induced lesions in rat carotid arteries. The large chondroitin sulphate as well as the small dermatan sulphate proteoglycan-cuprolinic blue precipitates show this alteration 2 weeks after balloon injury. We suggest that quantitative and qualitative alterations in the arterial proteoglycans occur in the pathogenesis of atherosclerosis in addition to the cell proliferation and lipid accumulation.